Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hiHep Bioartificial Liver after Extensive Hepatectomy
NCT05035108Phase 1Recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Sep 2021
- Primary completion
- Nov 2030
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in liver failure, sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Incidence of adverse events at 3 months. Started Sep 2021; status: recruiting.
02
Conditions
liver failure
Beyond the preview
Go deeper on NCT05035108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035108.